Efficacy and Safety of Liraglutide vs. Placebo When Added to Basal Insulin Analogues in Subjects with Type 2 Diabetes (LIRA-ADD2BASAL): A Randomized, Placebo-Controlled Trial

Autor:	Michael A. Nauck, Luis De Loredo, Jorma Lahtela, J Robin Conway, Helena W. Rodbard, Julio Rosenstock, Anand Boopalan, Andrew J. Ahmann, Karen Tornøe
Rok vydání:	2014
Předmět:	medicine.medical_specialty business.industry Liraglutide Endocrinology Diabetes and Metabolism Basal insulin Placebo-controlled study Lira General Medicine Type 2 diabetes Placebo medicine.disease Gastroenterology Endocrinology Internal medicine Internal Medicine medicine business medicine.drug
Zdroj:	Canadian Journal of Diabetes. 38:S7
ISSN:	1499-2671
DOI:	10.1016/j.jcjd.2014.07.017
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6cbddb5abb6b54e7b19532dd48ece0c8 https://doi.org/10.1016/j.jcjd.2014.07.017 Zobrazit plný text záznamu Full Text from ScienceDirect